Results 121 to 130 of about 314,513 (244)

Diffusion and Binding of Mismatch Repair Protein, MSH2, in Breast Cancer Cells at Different Stages of Neoplastic Transformation

, 2017
Justin Sigley, John Jarzen, Karin Scarpinato, Martin Guthold, Tracey Pu, Daniel Nelli, Josiah Low, Keith Bonin   +7 more
openalex   +2 more sources

Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.

, 2020
Yue Xiong
openalex   +1 more source

Interleukin (IL)‐5, Eosinophils and IL‐5 Pathway Inhibitors in Eosinophilic Granulomatosis with Polyangiitis.

Arthritis &Rheumatology, Accepted Article.
Alvise Berti, Christian Pagnoux
wiley   +1 more source

Non‐Syndromic Tumefactive Demyelinating Lesions in the Pediatric Population: Four Case Reports and Review of the Literature

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Introduction Tumefactive demyelinating lesions (TDLs) are large lesions (> 2 cm) seen in demyelinating syndromes such as multiple sclerosis, myelin oligodendrocyte glycoprotein antibody‐associated disorder, and neuromyelitis optica spectrum disorder. They rarely occur in children and most often have a monophasic course.
Elizabeth C. Ballinger, Hannah F. Todd, Jonathan M. Yarimi, Timothy E. Lotze, Nikita M. Shukla, Kristen S. Fisher, Alexander J. Sandweiss   +6 more
wiley   +1 more source

Endo180 and basement membrane stiffness induce OXPHOS and neoplastic transformation in aging prostate epithelia. [PDF]

NPJ Aging
Pastro L, Martínez J, Fontenla S, Chiale AC, Faulord A, Frade MP, Díaz AS, Martino-Kunsch R, Castro L, Schenk L, Quijano C, Sturge J, Rodríguez-Teja M.   +12 more
europepmc   +1 more source

Gastric Hyperplastic Polyps: A Benign Entity? Analysis of Recurrence and Neoplastic Transformation in a Cohort Study. [PDF]

GE Port J Gastroenterol, 2021
João M, Areia M, Alves S, Elvas L, Taveira F, Brito D, Saraiva S, Teresa Cadime A.   +7 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source

FRA1 (<i>FOSL1</i>) suppresses neoplastic transformation and modulates radiation responses via transcriptional control of mitogenic and stress-responsive networks. [PDF]

Front Cell Dev Biol
Al-Khayyat W, Laframboise T, Dougherty J, Mendonca MS, Boreham DR, Tai TC, Thome C, Tharmalingam S.   +7 more
europepmc   +1 more source

Neoplastic transformation of Chinese hamster cells in vitro after treatment with flavoring agents.

, 1987
Akiko Kasamaki, Toshio Yasuhara, Shozo Urasawa   +2 more
openalex   +2 more sources

Monocyte maturation pattern by flow cytometry expression of CD64, CD300e, and CD14 correlates to presence of myeloid neoplasm and helps identify blast equivalents in the setting of monocytic neoplasm

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract CD300e is a marker of mature monocytes in flow cytometry; however, there is limited detailed information on staining patterns in conjunction with other monocyte markers. We evaluated the flow cytometric staining patterns of CD64, CD14, and CD300e in 12 negative and 33 positive peripheral blood specimens and 16 negative and 56 positive bone ...
Jenny Zhang, Jacob Kaplan, Elizabeth Courville   +2 more
wiley   +1 more source